ThinkEquity
http://www.thinkequity.comThinkEquity offers research, investment banking, wealth management, and asset management services for institutional and individual investors.
View Older Stories View More Recent Stories
-
Mobilicom Limited Announces Pricing of USD $11.8 Million Public Offering and Nasdaq Listing
-
Mobilicom Limited Announces Pricing of USD $11.8 Million Public Offering and Nasdaq Listing
-
InvestorNewsBreaks — Save Foods Inc. (NASDAQ: SVFD) Closes on $4.8M Public Offering
-
Save Foods, Inc. Announces Closing of Public Offering
-
Save Foods, Inc. Announces Closing of Public Offering
-
Form X-17A-5/A THINKEQUITY LLC For: Dec 31
-
Form X-17A-5 THINKEQUITY LLC For: Dec 31
-
Forza X1, Inc. Announces Closing of Initial Public Offering and Exercise of Over-Allotment Option
-
InvestorNewsBreaks — Save Foods Inc. (NASDAQ: SVFD) Announces Proposed Underwritten Public Offering at $3 Per Share
-
KWESST Publicly Files a Registration Statement with the United States Securities and Exchange Commission for a Proposed Registered Offering in the United States and Dual-Listing on the Nasdaq Capital
-
Save Foods (SVFD) Prices 1.6M Share Offering at $3/sh
-
Save Foods Announces Pricing of Public Offering of Common Stock
-
Save Foods Announces Pricing of Public Offering of Common Stock
-
Save Foods (SVFD) Announces Proposed Stock Offering, Size not Disclosed
-
Save Foods Announces Proposed Public Offering of Common Stock
-
Save Foods Announces Proposed Public Offering of Common Stock
-
Forza X1, Inc. (FRZA) Prices 3M Share IPO at $5/sh
-
Forza X1, Inc. Announces Pricing of Initial Public Offering
-
Lantern Pharma Reports Second Quarter 2022 Financial Results and Operational Highlights
-
Alumis Appoints Sapna Srivastava, Ph.D., to its Board of Directors
-
MAIA Biotechnology Announces Closing of Initial Public Offering
-
MAIA Biotechnology (MAIA) Prices 2M Share Offering at $5/sh
-
MAIA Biotechnology Announces Pricing of Initial Public Offering
-
UPDATE -- AIM Stockholder Full Value Committee Announces Director Nominations for AIM Annual Meeting and Confirms Intent to Proceed with Proxy Solicitation
-
AIM Stockholder Full Value Committee Announces Director Nominations for AIM Annual Meeting and Confirms Intent to Proceed with Proxy Solicitation
-
Netcapital Inc. Announces Closing of Public Offering
-
Data I/O Announces Fireside Chat Hosted by Roth Capital Semiconductor Equity Research Analyst Suji Desilva
-
Hesperos, Inc (HESP) Files IPO Registration Statement
-
Netcapital (NCPL) Prices 1.2M Share and Warrant Offering at $4.15/sh
-
Netcapital Inc. Announces Pricing of Public Offering and Nasdaq Listing
-
Alliance Entertainment to Go Public Via Merger with Adara Acquisition Corp. (ADRA) in $480M Deal
-
Alliance Entertainment to Become an NYSE American Publicly Traded Company Via Business Combination with Adara Acquisition Corp. in $480 Million Transaction
-
FG Financial Group, Inc. Announces Closing of Public Offering
-
FG Financial Group, Inc (FGF) Prices 2.75M Offering at $1.58/sh
-
FG Financial Group, Inc. Announces Pricing of Public Offering
-
Turning Rock Partners Completes $20 Million Investment
-
SaverOne 2014 Ltd. Announces Closing of Public Offering and Nasdaq Listing
-
SaverOne 2014 (SVRE) Prices 2.94M Unit Offering at $4.13/unit
-
SaverOne 2014 Ltd. Announces Pricing of $13 Million Public Offering and Nasdaq Listing
-
SaverOne 2014 Ltd. Announces Pricing of $13 Million Public Offering and Nasdaq Listing
-
Hillstream BioPharma (HILS) Provides Corporate Update
-
Hillstream BioPharma Provides Corporate Update
-
Data I/O Announces Fireside Chat Series for the Investment Community
-
OKYO Pharma Limited Announces Closing of Public Offering and Nasdaq Listing
-
OKYO Pharma Limited Announces Closing of Public Offering and Nasdaq Listing
-
OKYO Pharma (OKYO) IPO Opens 13% Higher
-
OKYO Pharma Limited Announces Pricing of Initial Public Offering of ADSs in the U.S. with director participation
-
OKYO Pharma Limited Announces Pricing of Initial Public Offering of ADSs in the U.S. with director participation
-
OKYO Pharma Limited (OKYO) Prices 625K ADS IPO at $4/sh
-
OKYO Pharma Limited Announces Pricing of Public Offering and Nasdaq Listing

